Synta Pharmaceuticals Corp $5.06
|Trade Time:||Mar 10 08:10 PM Eastern Daylight Time|
|Change:||0.00 (0.00 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get SNTA Trend Analysis - it has underperformed the S&P 500 by 69%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|11/13/2013||Gollust Keith R||Director||150,000||$3.75||5.61%|
|11/13/2013||REARDON WILLIAM S||Director||13,333||$3.75||57.40%|
|11/13/2013||Bahcall Safi R||President and CEO||20,000||$3.75||0.98%|
|11/13/2013||Kovner Bruce||Senior Executive Officer||3,400,000||$3.75||80.00%|
|6/28/2013||Bahcall Safi R||President and CEO||10,000||$5.03||0.49%|
SNTA Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!